# Emulation of the SOUL Diabetes Trial in Healthcare Claims

> **NCT06659718** · — · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 43650 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Oral semaglutide
- **DRUG:** Sitagliptin

## Key facts

- **NCT ID:** NCT06659718
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-24
- **Primary completion:** 2025-02-13
- **Final completion:** 2025-02-13
- **Target enrollment:** 43650 (ACTUAL)
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06659718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06659718, "Emulation of the SOUL Diabetes Trial in Healthcare Claims". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06659718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*